Medical Condition News

RSS

Magical thinking may help consumers cope with stressful situations

Magical thinking, usually dismissed as na-ve and irrational, can actually help consumers cope with stressful situations like trying to lose weight, according to a new study in the Journal of Consumer Research.

16 Jun 2011

Non-invasive intervention can greatly improve patients' inhibitory control

Inhibitory control can be boosted with a mild form of brain stimulation, according to a study published in the June 2011 issue of Neuroimage, Elsevier's Journal of Brain Function.

16 Jun 2011

UC Irvine researchers discover top six risk factors for weight loss surgery

University of California at Irvine (UC Irvine) researchers reviewed data from more than 100,000 bariatric surgery patients and discovered the top six risk factors that could help doctors and patients predict, evaluate, reduce or avoid in-hospital mortality after weight loss surgery.

16 Jun 2011

Fred Hutchinson Cancer Research Center to relaunch online smoking-cessation study

Fred Hutchinson Cancer Research Center announced today that it is relaunching an online study to help people quit smoking. The study, called WebQuit, is enrolling adult smokers nationwide. Participation is free to eligible individuals.

16 Jun 2011

Train the brain to manage chronic pain

How do you function when chronic pain is a part of your daily life? The UC San Diego Center for Mindfulness (UCSD CFM) at UC San Diego Health System offers a novel program to help people who are dealing with chronic pain "train their brains" to lessen their experience of discomfort and, in some cases, eliminate it.

16 Jun 2011

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

InNexus Biotechnology Inc., a biopharmaceutical company creating and developing innovative solutions for cancer, inflammation and other difficult-to-treat diseases, announced today that it has filed for patent protection covering a novel antibody product for Age-related Macular Degeneration (AMD) and other eye disorders.

16 Jun 2011

Cambridge Biomedical, Neogenix partner to develop ELISA assays for pancreatic and colorectal cancer

Neogenix Oncology, Inc. is pleased to announce it has signed an agreement with Cambridge Biomedical, Inc, based in Boston, MA, for the development of its pancreatic and colorectal cancer diagnostic serum ELISA assays.

16 Jun 2011

ISSCR honors UCSF cancer scientist with 2011 Outstanding Young Investigator Award

UCSF's Robert Blelloch, MD, PhD, has received the 2011 Outstanding Young Investigator Award from the International Society for Stem Cell Research, for his pioneering research on the role of molecular tools known as microRNAs in embryonic stem cells and cancer.

16 Jun 2011

ACC to expand partnership and strategic alliance with FIGMD

FIGMD, Inc. today announced the American College of Cardiology (ACC) will expand its partnership and strategic alliance with FIGMD by making an equity investment.

16 Jun 2011

Healthy diet, antioxidants, critical nutrients and activities may provide the foundation to youthful living

As the baby boomer generation continues to increase in age, so does its passion to remain youthful, both inside and out. Beating the clock is now a multi-faceted, science-driven industry. From its age-old quests to find the elixir of life, to modern exploration of how microcellular activity contributes to metabolic breakdown, scientific research continues to advance its goals to enhance bodily energy, vigour and performance, and fade or stall the visible signs of aging.

16 Jun 2011

Liraglutide medication can help treat type 1 diabetes

Results of a small, observational study conducted at the University at Buffalo suggest that liraglutide, an injectable medication used to treat type 2 diabetes, also helps type 1 diabetics on insulin achieve optimal control of their blood glucose levels.

16 Jun 2011

Potential new drug therapies targeting genetic mutations benefit lung-cancer patients

Some lung-cancer patients at UT Southwestern Medical Center are responding well to potential new drug therapies targeting genetic mutations. Their participation in a national study is helping to forge new avenues to attack the disease.

16 Jun 2011

Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announces that data from its Phase 2 PV-10 metastatic melanoma study will be presented at two upcoming melanoma conferences.

16 Jun 2011

Scientists discover new cell type in the immune system

A team of Australian scientists has discovered a new type of cell in the immune system. The new cell type, a kind of white blood cell, belongs to a family of T-cells that play a critical role in protection against infectious disease.

16 Jun 2011

Olive oil may help prevent stroke in older people

A new study suggests that consuming olive oil may help prevent a stroke in older people. The research is published in the June 15, 2011, online issue of Neurology, the medical journal of the American Academy of Neurology.

16 Jun 2011

ViroPharma receives European Centralized Marketing Authorization for Cinryze for treatment of HAE

ViroPharma Incorporated today announced that the European Commission has granted ViroPharma Centralized Marketing Authorization for Cinryze (C1 inhibitor [human]) in adults and adolescents with hereditary angioedema (HAE) for routine prevention, pre-procedure prevention and acute treatment of angioedema attacks.

16 Jun 2011

Exposure to asbestos can cause genetic somatic mutations in mammals

Mice inhabiting an area known for its high concentration of asbestos-contaminated dust, have a higher level of genetic somatic mutations, compared with other regions where asbestos pollution levels are lower.

16 Jun 2011

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

The U.S. Food and Drug Administration today approved Nulojix to prevent acute rejection in adult patients who have had a kidney transplant. The drug is approved for use with other immunosuppressants -- specifically basiliximab, mycophenolate mofetil, and corticosteroids.

16 Jun 2011

USPTO issues patent to EndoSphere's noninvasive device for treatment of obesity

EndoSphere Inc., a medical technology company that holds 23 U.S. and international issued and pending patents, announced today that the U.S. Patent and Trademark Office has issued the company a patent covering the use of its endoscopically implantable devices for the treatment of metabolic diseases, including obesity and type 2 diabetes.

16 Jun 2011

Conference to discuss new diagnostic and treatment options for cognitive impairments in MS

On June 21-23, 2011, the New York Academy of Sciences will bring together physicians, neurologists, clinical neuropsychologists, cellular and molecular biologists and patient advocates to discuss current challenges and potential solutions for improving diagnosis, treatment and management of the cognitive symptoms of MS.

15 Jun 2011

Medical Condition News

Magical thinking may help consumers cope with stressful situations

Non-invasive intervention can greatly improve patients' inhibitory control

UC Irvine researchers discover top six risk factors for weight loss surgery

Fred Hutchinson Cancer Research Center to relaunch online smoking-cessation study

Train the brain to manage chronic pain

InNexus files patent protection for new Age-related Macular Degeneration therapeutic

Cambridge Biomedical, Neogenix partner to develop ELISA assays for pancreatic and colorectal cancer

ISSCR honors UCSF cancer scientist with 2011 Outstanding Young Investigator Award

ACC to expand partnership and strategic alliance with FIGMD

Healthy diet, antioxidants, critical nutrients and activities may provide the foundation to youthful living

Liraglutide medication can help treat type 1 diabetes

Potential new drug therapies targeting genetic mutations benefit lung-cancer patients

Provectus PV-10 Phase 2 trial data on metastatic melanoma to be presented at two conferences

Scientists discover new cell type in the immune system

Olive oil may help prevent stroke in older people

ViroPharma receives European Centralized Marketing Authorization for Cinryze for treatment of HAE

Exposure to asbestos can cause genetic somatic mutations in mammals

Bristol-Myers Squibb receives FDA approval for Nulojix to prevent organ rejection after kidney transplant

USPTO issues patent to EndoSphere's noninvasive device for treatment of obesity

Conference to discuss new diagnostic and treatment options for cognitive impairments in MS

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News